Table 2.
Diagnosis and Medications of Participants in Chronic Kidney Disease (CKD) Stages 1 to 5 Subdivided Into Three Groups According to Their Stage of Renal Impairment (N = 100).
| CKD Stage 1 (n = 23) | CKD Stages 2 and 3 (n = 46) | CKD Stages 4 and 5 (n = 31) | |
|---|---|---|---|
| Diagnosis | |||
| Glomerular disease | 11 | 27 | 18 |
| Hypertensive nephrosclerosis | 2 | 5 | 3 |
| Tubulointerstial disease | 2 | 5 | 2 |
| Vascular disease | 3 | 2 | 4 |
| Polycystic kidney disease | 5 | 7 | 4 |
| Medications | |||
| Statins | 5 | 17 | 14 |
| Angiotensin-converting enzyme inhibitors | 11 | 23 | 17 |
| Angiotensin receptor blockers | 2 | 20 | 18 |
| Diuretic | 0 | 8 | 16 |
| Beta-blockers | 3 | 10 | 17 |
| Calcium channel blockers | 4 | 18 | 13 |